Individual and social factors associated with participation in treatment programs for drug users

Substance Use and Misuse

Volumn 43, Issue 12-13, 2008, Pages 1865-1881

  Gyarmathy, V Anna ^a   Latkin, Carl A ^b  

^a EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Drug user treatment; Injecting and noninjecting drug users; Interaction; Relapse; Sustained treatment; Treatment entry; Treatment retention

Indexed keywords

METHADONE;

ADULT; ARTICLE; COMPARATIVE STUDY; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG USE; EDUCATION; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PRIORITY JOURNAL; SELF HELP; SELF REPORT; SOCIAL ASPECT; STRUCTURED QUESTIONNAIRE; TREATMENT PLANNING;

EID: 57349182264     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080802293038     Document Type: Article

References (45)

1. AA World Services. (2002). Alcoholics Anonymous: The story of how many thousands of men and women have recovered from alcoholism. New York, New York.
2. Appel, P. W., Ellison, A. A., Jansky, H. K., Oldak, R. (2004). Barriers to enrollment in drug abuse treatment and suggestions for reducing them: Opinions of drug injecting street outreach clients and other system stakeholders. American Journal of Drug and Alcohol Abuse 30:129-153.
3. Beardsley, K., Wish, E. D., Fitzelle, D. B., O'Grady, K., Arria, A. M. (2003). Distance traveled to outpatient drug treatment and client retention. Journal of Substance Abuse Treatment 25:279-285.
4. Booth, R. E., Corsi, K. F., Mikulich, S. K. (2003). Improving entry to methadone maintenance among out-of-treatment injection drug users. Journal of Substance Abuse Treatment 24:305-311.
5. Booth, R. E., Corsi, K. F., Mikulich-Gilbertson, S. K. (2004). Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug and Alcohol Dependence 74:177-185.
6. Booth, R. E., Kwiatkowski, C., Iguchi, M. Y., Pinto, F., John, D. (1998). Facilitating treatment entry among out-of-treatment injection drug users. Public Health Reports 113(Suppl. 1):116-128.
7. Broekhuysen, E. S. (2000). Methadone fact sheet: White House Office of National Drug Control Policy. Retrieved from http://www.whitehousedrugpolicy. gov/publications/factsht/methadone/.
8. Compton, W. M., Thomas, Y. F., Stinson, F. S., Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry 64:566-576.
9. Costenbader, E. C., Astone, N. M., Latkin, C. A. (2006). The dynamics of injection drug users' personal networks and HIV risk behaviors. Addiction 101:1003-1013.
10. Ferri, C. P., Gossop, M., Rabe-Hesketh, S. Laranjeira, R. R. (2002). Differences in factors associated with first treatment entry and treatment re-entry among cocaine users. Addiction 97:825-832.
11. Fiorentine, R. (1999). After drug treatment: Are 12-step programs effective in maintaining abstinence? American Journal of Drug and Alcohol Abuse 25:93-116.
12. Fiorentine, R. Hillhouse, M. P. (2000). Drug treatment and 12-step program participation: The additive effects of integrated recovery activities. Journal of Substance Abuse Treatment 18:65-74.
13. Gallus, S., Schiaffino, A., La Vecchia, C., Townsend, J., Fernandez, E. (2006). Price and cigarette consumption in Europe. Tobacco Control 15:114-119.
14. Gifford, E., Humphreys, K. (2007). The psychological science of addiction. Addiction 102:352-361.
15. Gilman, S. M., Galanter, M., Dermatis, H. (2001). Methadone Anonymous: A 12-Step Program for Methadone Maintained Heroin Addicts. Journal of Substance Abuse 22:247-256.
16. Goehl, L., Nunes, E., Quitkin, F., Hilton, I. (1993). Social networks and methadone treatment outcome: The costs and benefits of social ties. American Journal of Drug and Alcohol Abuse 19:251-262.
17. Gogineni, A., Stein, M. D., Friedmann, P. D. (2001) Social relationships and intravenous drug use among methadone maintenance patients. Drug and Alcohol Dependence 64:47-53.
18. Gruber, J., Sen, A., Stabile, M. (2003). Estimating price elasticities when there is smuggling: The sensitivity of smoking to price in Canada. Journal of Health Economics 22:821-842.
19. Gyarmathy, V. A. Neaigus, A. (2005). Marginalized and socially integrated groups of IDUs in Hungary: Potential bridges of HIV infection. Journal of Urban Health 82:iv101-iv112
20. Hartel, D. M. Schoenbaum, E. E. (1998). Methadone treatment protects against HIV infection: Two decades of experience in the Bronx, New York City. Public Health Reports 113(Suppl. 1):107-115.
21. Hosmer, D. W. Lemeshow, S. (1989). Applied logistic regression. John Wiley, New York, NY.
22. Knight, K., Holcom, M., Simpson, D. D. (1994). TCU Psychosocial Functioning and Motivation Scales: Manual on psychometric properties. Fort Worth, Texas: Texas Christian University Institute of Behavioral Research.
23. Knight, D. K., Simpson, D. D. (1996). Influences of family and friends on client progress during drug abuse treatment. Journal of Substance Abuse 8:417-429.
24. Langendam, M. W., van Brussel, G. H., Coutinho, R. A., van Ameijden, E. J. (2000). Methadone maintenance and cessation of injecting drug use: Results from the Amsterdam Cohort Study. Addiction 95:591-600.
25. Latkin, C. A., Hua, W., Davey, M. A. (2004). Factors associated with peer HIV prevention outreach in drug-using communities. AIDS Education and Prevention 16:499-508.
26. Latkin, C.A., Sherman, S., Knowlton, A. (2003). HIV prevention among drug users: Outcome of a network-oriented peer outreach intervention. Health Psychology 22:332-339.
27. Laudet, A. B. (2003). Attitudes and beliefs about 12-step groups among addiction treatment clients and clinicians: Toward identifying obstacles to participation. Substance Use and Misuse 38:2017-2047.
28. Laudet, A. B., Magura, S., Cleland, C. M., Vogel, H. S., Knight, E. L. (2003). Predictors of retention in dual-focus self-help groups. Community Mental Health Journal 39:281-297.
29. Lloyd, J. J., Ricketts, E. P., Strathdee, S. A., Cornelius, L. J., Bishai, D., Huettner, S., et al. (2005). Social contextual factors associated with entry into opiate agonist treatment among injection drug users. American Journal of Drug and Alcohol Abuse 31:555-570.
30. Maddux, J. F., Desmond, D. P. (1992). Methadone maintenance and recovery from opioid dependence. American Journal of Drug and Alcohol Abuse 18:63-74.
31. Magura, S., Rosenblum, A., Rodriguez, E. M. (1998). Changes in HIV risk behaviors among cocaine-using methadone patients. Journal of Addictive Diseases 17:71-90.
32. Mattick, R. P., Breen, C., Kimber, J., Davoli, M., Breen, R. (2003). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 2003, Issue 1, Art No. CD002209. DOI: 10.1002/14651858.CD002209
33. Metzger, D. S., Navaline, H., Woody, G. E. (1998). Drug abuse treatment as AIDS prevention. Public Health Reports, 113(Suppl. 1):97-106.
34. National Institutes on Drug Abuse. (1999). Principles of drug addiction treatment - A research-based guide. Bethesda, MD: National Institutes of Health.
35. Office of National Drug Control Policy. (2004). Washington, DC: Executive Office of the President. Retrevied July 31, 2008 from www.whitehousedrugpolicy. gov
36. Prochaska, J., Redding, C., Evers, K. (1997). The Transtheoretical Model and Stages of Change. In K. Glanz, F.M. Lewis, & B.K. Rimer (Eds.), Health Behavior and Health Education: Theory, Research and Practice (pp. 60-84). San Francisco, CA: Jossey-Bass.
37. Schutz, C. G., Rapiti, E., Vlahov, D., Anthony, J. C. (1994). Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug and Alcohol Dependence 36:129-138.
38. Shah, N. G., Celentano, D. D., Vlahov, D., Stambolis, V., Johnson, L., Nelson, K. E., et al. (2000). Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS 14:2035-2043.
39. Stark, K., Muller, R., Bienzle, U., Guggenmoos-Holzmann, I. (1996). Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin. Journal of Epidemiology and Community Health 50:534-537.
40. Termorshuizen, F., Krol, A., Prins, M., Geskus, R., van den Brink, W., van Ameijden, E. J. (2005). Prediction of relapse to frequent heroin use and the role of methadone prescription: An analysis of the Amsterdam Cohort Study among drug users. Drug and Alcohol Dependence 79:231-240.
41. Townsend, J., Roderick, P., Cooper, J. (1994). Cigarette smoking by socioeconomic group, sex, and age: Effects of price, income, and health publicity. British Medical Journal 309:923-927.
42. United Nations Office on Drugs and Crime. (2007). World Drug Report. United Nations. Vienna, Austria.
43. Vaughn, T., Sarrazin, M. V., Saleh, S. S., Huber, D. L., Hall, J. A. (2002). Participation and retention in drug abuse treatment services research. Journal of Substance Abuse Treatment 23:387-397.
44. Wasserman, D. A., Stewart, A. L., Delucchi, K. L. (2001). Social support and abstinence from opiates and cocaine during opioid maintenance treatment. Drug and Alcohol Dependence 65:65-75.
45. Zule, W. A. Desmond, D. P. (2000). Factors predicting entry of injecting drug users into substance abuse treatment. American Journal of Drug and Alcohol Abuse 26:247-261.